Skip to main content

Table 5 Relationships between the prognostic (+/- relapses) and the mRNA levels of BRCA2, DNMT3B and CCNE1 in 104 ERα-positive postmenopausal breast tumors

From: Identification of a three-gene expression signature of poor-prognosis breast carcinoma

GENES

Tumors without relapses (n = 73)

Tumors with relapses (n = 31)

P a

ROC-AUCb

BRCA2

4.7 (1.0–23.6c

7.5 (1.4–38.4)

0.0018

0.694 (0.58–0.80)d

DNMT3B

3.6 (1.0–27.8)

6.2 (2.3–74.1)

0.00052

0.716 (0.61–0.82)

CCNE1

6.4 (1.0–46.2)

9.0 (1.3–62.8)

0.028

0.636 (0.51–0.76)

  1. a:P value, Mann-Whitney U test.
  2. b:ROC (Receiver Operating Characteristics) – AUC (Area Under Curve) analysis
  3. c:Median (range) of gene mRNA levels
  4. d:AUC value (95% confidence interval)